Zimbabwe has rejected a major US health deal valued at 367 million US dollars (£272m) spanning five years because of Washington's request for sensitive information.
This move was revealed following a government memo dated December was disclosed, revealing that Head of State Emmerson Mnangagwa deemed the arrangement was "lopsided".
A government spokesperson later clarified that the US was seeking biological samples for scientific study and commercial purposes while was not willing to guarantee the resulting advantages from future vaccines.
"We are forced to start the difficult and regrettable task of winding down our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy said the US had furnished over $1.9bn in health funding to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has urged more dialogue to secure a agreement acceptable to both sides so the nation's vital HIV treatment initiative can proceed.
Wider Context
This development follows a similar situation in neighbouring Kenya, where a high court suspended a related health funding agreement following legal challenges were filed about the security of Kenyans' medical information.
After returning to office recently, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
The agency had managed assistance for the American government, but Trump claimed its expenditure was "inefficient" and his government was pursuing direct bilateral agreements to boost openness and responsibility.
As per reports, 16 nations in Africa have so far signed these new agreements, constituting more than $18.3bn of fresh investment.
Specifics of the Rejected Agreement
This assistance for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this collaboration could have provided significant advantages for the people of Zimbabwe, particularly the 1.2 million presently receiving antiretroviral therapy via US-supported initiatives," the Ambassador added.
However, official spokesman Nick Mangwana said the arrangement was "unfair".
"Our nation was requested to surrender its genetic material and health information for a long time, with no equivalent guarantee of access to any medical innovations – like new medicines or tests – that could result from that shared data," his statement read.
"Effectively, our nation would supply the basic resources for medical research with no certainty that the end products would be available to our people if a future health crisis arise."
Sovereignty and Global Health
Mangwana further noted that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were undermining systems already set up via the global organization.
Mangwana cited its Pathogen Access and Benefit Sharing system designed to deal with future global health emergencies.
"This mechanism is designed to guarantee that when a country provides its information, the resulting advantages – including medicines and cures – are shared equitably, not monopolised solely by those with the resources to develop them."
Zimbabwe's reservations over the US deal "must not be interpreted as anti-American sentiment," he added.
"We encourage ongoing dialogue with our American counterparts on how subsequent collaboration might be designed in a way that honours the independence and dignity of both nations."
Health Experts Reaction
A leading public health body stated it recognised the government's concerns, but suggested that talks should continue considering much of the country's Aids initiatives relied on external financing.
"In cases where specific concerns arise, such as those involving information security or implementation frameworks, these can often be resolved through technical clarification and negotiated safeguards," the group said.
The situation underscores the ongoing tensions between accepting vital foreign assistance and safeguarding local interests in an ever more interconnected world.